Showing results (141-150 of 199) with videos related to
Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Suramin in combination with mitomycin C in hormone-resistant prostate cancer. A phase II clinical studyB L Rapoport, G Falkson, J I Raats, et al.American Journal of Clinical Oncology|March 14, 1998
Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181)A Y Chang, M Putt, K J Pandya, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group StudyG Falkson, R S Gelman, D C Tormey, et al.Cancer|July 15, 1985
The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerG Falkson, R S Gelman, D C Tormey, et al.Cancer Genetics and Cytogenetics|February 1, 1991
Trisomy 5 in Ph+ chronic myeloid leukemia in association with megakaryocytosisS M Ansell, B L Rapoport, M A Coccia-Portugal, et al.Breast Cancer Research and Treatment|January 1, 1981
A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancerD C Tormey, R Gelman, P R Band, et al.Cancer|October 1, 1989
Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group StudyR T Skeel, J W Andersen, D C Tormey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Anxiety levels in patients randomized to adjuvant therapy versus observation for early breast cancerB R Cassileth, M W Knuiman, M D Abeloff, et al.American Journal of Clinical Oncology|October 1, 1985
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot studyK J Pandya, F M Muggia, R T Skeel, et al.Cancer Clinical Trials|January 1, 1981
Vindesine. A phase II trial in advanced breast cancer patientsH I Robins, D C Tormey, M J Skelley, et al.Pageof 20